June 12, 2019
New York, June 12, 2019 -- Oak HC/FT, a premier venture growth-equity fund investing in tech-enabled healthcare and financial services companies, announced today that Jenn Adams has joined the firm as an Executive in Residence (EIR). In this role, Jenn will be responsible for developing new tech-enabled healthcare businesses through a combination of building from scratch and investing in early- and growth-stage companies.
Jenn has extensive experience leading, transforming and driving growth in both Fortune 500 public and private equity-backed companies. Most recently, Jenn served as SVP & President, Clinical Product Solutions for AmerisourceBergen, a Fortune 11 healthcare corporation.
“Jenn is a distinguished leader in the healthcare community, and we’re proud to welcome her to our team,” said Andrew Adams, Co-Founder & General Partner at Oak HC/FT. “Her expertise and insights will significantly strengthen our ability to identify promising digital health companies and accelerate their path to success.”
“I’m thrilled to join a team that shares my belief in the importance of providing value through patient centric solutions,” said Jenn Adams. “The patient experience is an important driver for an improved healthcare system, and I look forward to working with the team at Oak HC/FT to build and invest in companies that enable a better experience.”
Prior to her role leading Clinical Product Solutions at AmerisourceBergen, Jenn served as President of PharMEDium. Under her leadership, the company grew to be a prominent market leader in the outsourced pharmacy services industry. Jenn also has more than 25 years of sales, marketing, training and product development experience, including positions at Fenwal and Baxter Healthcare Corporation.
Jenn’s appointment follows other recent additions to Oak HC/FT, including Allen Miller, who joined as a Principal, and Michael Vaughan, who joined as a fintech-focused EIR.